Liu Weiwei, Zhang Shujun, Zhang Yuli, Yue Zhuoli, Yin Guiru
Department of Otorhinolaryngology, Cangzhou Central Hospital, Cangzhou 061000, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Jul;27(13):722-5.
To investigate the relationship between the immune status of adenoids and secretory otitis media (SOM).
The adenoids tissue samples of 30 cases of recurrent secretory otitis media (SOM), 17 cases of non-recurrent secretory otitis media and 20 cases of the adenoids hypertrophy without SOM were studied by immunohistochemical method.
The expression of PCNA, BCL-2, CD4+, CD8+ cells and CD4+/CD8+ in recurrent SOM tissue were 30.85 +/- 1.73, 21.27 +/- 1.25, 41.90 +/- 9.07; 20.45 +/- 7.08 and 2.10 +/- 0.17, respectively, which was remarkably higher than those of non-recurrent SOM, (25.50 +/- 1.66, 14.23 +/- 1.06, 17.40 +/- 6.85, 13.02 +/- 5.88, 1.33 +/- 0.11, respectively) and those of simple adenoid hypertrophy (25.25 +/- 1.75, 14.05 +/- 1.02, 16.30 +/- 8.21, 11.15 +/- 5.71 and 1.39 +/- 0.15, respectively) (P < 0.01); the difference of the expression of PCNA, BCL-2, CD4+, CD8+ and CD4+/CD8+ between the latter two groups was not significant. Differences of the gender or the size were not significant (P > 0.05). In group of simple adenoid hypertrophy, PCNA in the subgroup of the age 3 to 6 was significantly higher than those in the other groups (P < 0.05).
In adenoid tissues of recurrent SOM patients, the activities of T-lymphocyte subsets cells in hypertrophic status increase, the adenoids enlarge and local immunity enhances. The age and gender have nothing to do with the SOM, but low age is one of the influencing factors of adenoid hypertrophy. Therefore, adenoidectomy for recurrent SOM patients with adenoid hypertrophy should be carried out as early as possible.
探讨腺样体免疫状态与分泌性中耳炎(SOM)之间的关系。
采用免疫组织化学方法对30例复发性分泌性中耳炎患者、17例非复发性分泌性中耳炎患者及20例无分泌性中耳炎的腺样体肥大患者的腺样体组织样本进行研究。
复发性SOM组织中PCNA、BCL-2、CD4⁺、CD8⁺细胞及CD4⁺/CD8⁺的表达分别为30.85±1.73、21.27±1.25、41.90±9.07、20.45±7.08及2.10±0.17,显著高于非复发性SOM组(分别为25.50±1.66、14.23±1.06、17.40±6.85、13.02±5.88、1.33±0.11)及单纯腺样体肥大组(分别为25.25±1.75、14.05±1.02、16.30±8.21、11.15±5.71及1.39±0.15)(P<0.01);后两组之间PCNA、BCL-2、CD4⁺、CD8⁺及CD4⁺/CD8⁺表达差异无统计学意义。性别及大小差异无统计学意义(P>0.05)。在单纯腺样体肥大组中,3至6岁亚组的PCNA显著高于其他组(P<0.05)。
复发性SOM患者腺样体组织中,处于肥大状态的T淋巴细胞亚群细胞活性增加,腺样体增大,局部免疫增强。年龄和性别与SOM无关,但低年龄是腺样体肥大的影响因素之一。因此,对于复发性SOM合并腺样体肥大的患者应尽早行腺样体切除术。